Headquarters
L 9 31 QUEEN ST, MELBOURNE, Victoria 3000, AU
MELBOURNE, Victoria, AU
From the company
ENA Respiratory is a clinical-stage pharmaceutical company headquartered in Melbourne, Australia, with operations in the USA. It develops antiviral host defense enhancers for the prevention of severe complications from respiratory viral infections in vulnerable populations. Its lead product is INNA-051, a first-in-class TLR2/6 agonist developed as a self-administered nasal product with a weekly dosing regimen. The company was formed in 2020 as a spin-off from ENA Therapeutics Pty Ltd.
L 9 31 QUEEN ST, MELBOURNE, Victoria 3000, AU
Quantities, certifications, and timing.